{
    "relation": [
        [
            "Feature key",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti"
        ],
        [
            "Position(s)",
            "218 \u2013 218",
            "220 \u2013 220",
            "369 \u2013 369",
            "460 \u2013 460",
            "556 \u2013 556",
            "559 \u2013 559",
            "586 \u2013 586",
            "777 \u2013 777",
            "1247 \u2013 1247",
            "1247 \u2013 1247",
            "1248 \u2013 1250"
        ],
        [
            "Length",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "3"
        ],
        [
            "Description",
            "R \u2192 C.1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.5 NIEHS SNPs program Submitted (MAR-2007) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS CYS-218; ILE-220; VAL-556; SER-559; HIS-586; ALA-777; LEU-1247 AND LYS-1247. Corresponds to variant rs6094752 [ dbSNP | Ensembl ].",
            "R \u2192 I.1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.5 NIEHS SNPs program Submitted (MAR-2007) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS CYS-218; ILE-220; VAL-556; SER-559; HIS-586; ALA-777; LEU-1247 AND LYS-1247.",
            "L \u2192 F. Corresponds to variant rs6094756 [ dbSNP | Ensembl ].",
            "G \u2192 R. Corresponds to variant rs1052765 [ dbSNP | Ensembl ].",
            "I \u2192 V.1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.5 NIEHS SNPs program Submitted (MAR-2007) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS CYS-218; ILE-220; VAL-556; SER-559; HIS-586; ALA-777; LEU-1247 AND LYS-1247. Corresponds to variant rs72645272 [ dbSNP | Ensembl ].",
            "P \u2192 S.1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.5 NIEHS SNPs program Submitted (MAR-2007) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS CYS-218; ILE-220; VAL-556; SER-559; HIS-586; ALA-777; LEU-1247 AND LYS-1247. Corresponds to variant rs2230781 [ dbSNP | Ensembl ].",
            "Q \u2192 H.1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.5 NIEHS SNPs program Submitted (MAR-2007) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS CYS-218; ILE-220; VAL-556; SER-559; HIS-586; ALA-777; LEU-1247 AND LYS-1247. Corresponds to variant rs2230782 [ dbSNP | Ensembl ].",
            "S \u2192 A.1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.5 NIEHS SNPs program Submitted (MAR-2007) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS CYS-218; ILE-220; VAL-556; SER-559; HIS-586; ALA-777; LEU-1247 AND LYS-1247. Corresponds to variant rs2230783 [ dbSNP | Ensembl ].",
            "M \u2192 K.1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.5 NIEHS SNPs program Submitted (MAR-2007) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS CYS-218; ILE-220; VAL-556; SER-559; HIS-586; ALA-777; LEU-1247 AND LYS-1247.",
            "M \u2192 L.1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.5 NIEHS SNPs program Submitted (MAR-2007) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS CYS-218; ILE-220; VAL-556; SER-559; HIS-586; ALA-777; LEU-1247 AND LYS-1247.",
            "Missing .2 Publications Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.2 \"Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300.\" Chen H., Lin R.J., Schiltz R.L., Chakravarti D., Nash A., Nagy L., Privalsky M.L., Nakatani Y., Evans R.M. Cell 90:569-580(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 4), ENZYME ACTIVITY, VARIANT 1248-GLN--GLN-1250 DEL. Ref.4 \"RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2.\" Li H., Gomes P.J., Chen J.D. Proc. Natl. Acad. Sci. U.S.A. 94:8479-8484(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5), INTERACTION WITH VDR; RARA; PPARA; RXRA; THRA AND ESR, VARIANT 1248-GLN--GLN-1250 DEL."
        ],
        [
            "Graphical view",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            ""
        ],
        [
            "Feature identifier",
            "VAR_053527",
            "VAR_060695",
            "VAR_053528",
            "VAR_013831",
            "VAR_060696",
            "VAR_013832",
            "VAR_013833",
            "VAR_053529",
            "VAR_060697",
            "VAR_060698",
            "VAR_013834"
        ],
        [
            "Actions",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            ""
        ]
    ],
    "pageTitle": "NCOA3 - Nuclear receptor coactivator 3 - Homo sapiens (Human)",
    "title": "",
    "url": "http://www.uniprot.org/uniprot/Q9Y6Q9",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 25,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438044160065.87/warc/CC-MAIN-20150728004240-00307-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 797468623,
    "recordOffset": 797403669,
    "tableOrientation": "HORIZONTAL",
    "TableContextTimeStampAfterTable": "{222924=The sequence of this isoform differs from the canonical sequence as follows: \u00a0\u00a0\u00a0\u00a0\u00a0321-321: E\u00a0\u2192\u00a0EVTSDGIFSPT \u00a0\u00a0\u00a0\u00a0\u00a0837-901: Missing. \u00a0\u00a0\u00a0\u00a0\u00a0903-917: Missing. \u00a0\u00a0\u00a0\u00a0\u00a01214-1217: Missing., 215051=The sequence of this isoform differs from the canonical sequence as follows: \u00a0\u00a0\u00a0\u00a0\u00a0321-321: E\u00a0\u2192\u00a0EVTSDGIFSPT \u00a0\u00a0\u00a0\u00a0\u00a0903-917: Missing. \u00a0\u00a0\u00a0\u00a0\u00a01214-1217: Missing., 230702=The sequence of this isoform differs from the canonical sequence as follows: \u00a0\u00a0\u00a0\u00a0\u00a01214-1217: Missing.}",
    "lastModified": "Wed, 22 Jul 2015 00:00:00 GMT",
    "textBeforeTable": "Natural variant The length of the poly-Gln region is polymorphic in the normal population. <p>Provides information on polymorphic variants. If the variant is associated with a disease state, the description of the latter can be found in the <a href=\"/manual/involvement_in_disease\">\u2018Involvement in disease\u2019</a> subsection.</p><p><a href='../manual/polymorphism' target='_top'>More...</a></p>Polymorphismi DG \u2192 EA in AAC51663 (PubMed:9238002).Curated 2 131\u00a0\u2013\u00a0132 <p>Reports difference(s) between the canonical sequence (displayed by default in the entry) and the different sequence submissions merged in the entry. These various submissions may originate from different sequencing projects, different types of experiments, or different biological samples. Sequence conflicts are usually of unknown origin.</p><p><a href='../manual/conflict' target='_top'>More...</a></p>Sequence conflicti Actions Feature identifier Graphical view Description Length Position(s) Feature key Experimental InfoBLASTProtParamProtScaleCompute pI/MWPeptideMassPeptideCutterGO <p>The checksum is a form of redundancy check that is calculated from the sequence. It is useful for tracking sequence updates.</p> <p>It should be noted that while, in theory, two different sequences could have the same",
    "textAfterTable": "Alternative sequence Feature key Position(s) Length Description Graphical view Feature identifier Actions <p>Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.</p><p><a href='../manual/var_seq' target='_top'>More...</a></p>Alternative sequencei 321\u00a0\u2013\u00a0321 1 E \u2192 EVTSDGIFSPT in isoform 3 and isoform 4. 1 Publication <p>Manually curated information that is based on statements in scientific articles for which there is no experimental support.</p> <p><a href=\"/manual/evidences#ECO:0000303\">More\u2026</a></p> Manual assertion based on opinion ini Ref.2 \"Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300.\" Chen H., Lin R.J., Schiltz R.L., Chakravarti D., Nash A., Nagy L., Privalsky M.L., Nakatani Y., Evans R.M. Cell 90:569-580(1997) [ PubMed] [ Europe PMC] [ Abstract] Cited for: NUCLEOTIDE SEQUENCE",
    "hasKeyColumn": false,
    "keyColumnIndex": -1,
    "headerRowIndex": 0
}